InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

  • PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods® IBS

  • inFoods® IBS provides personalized identification of food triggers to substantially improve IBS-related symptoms like bloating, abdominal pain, diarrhea, and constipation

IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) — Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company focused on innovative gastroenterology diagnostics, today announced that the American Medical Association CPT editorial panel has issued a Current Procedural Terminology (CPT®) code in the Proprietary Laboratory Analysis (PLA) code category for the Company’s inFoods® IBS test.

This newly granted PLA code assigns a unique identifier to the test, allowing for the submission of claims to Medicare and private insurers for the Company’s inFoods IBS test once the code becomes effective on October 1, 2025. The PLA code represents a next step on the pathway to expand patient access to the inFoods® IBS test.

Milestone to Expand Patient Access

The issuance of a PLA code represents a milestone in Biomerica’s commercialization strategy and its efforts to expand access to inFoods® IBS. A test specific billing code allows for transparency in claims submission and adjudication for inFoods® IBS.

“This is an important step toward enabling more patients to access our inFoods® IBS test through health insurance reimbursement,” said Zack Irani, CEO of Biomerica. “The PLA code not only streamlines the claims process but also supports our broader goal of helping more patients and physicians adopt a personalized, non-drug approach to managing IBS symptoms by adoption of our inFoods® technology.”

“Securing a PLA code for our inFoods® IBS test is a milestone that strengthens our commercial strategy,” said Scott Madel, Chief Commercial Officer of Biomerica. “It positions us to accelerate insurance reimbursement efforts and opens the door to reaching millions of patients who are actively seeking better, more personalized solutions for their IBS symptoms.”

A Clinically Actionable Solution for IBS Patients

The inFoods® IBS test is a first-of-its-kind diagnostic that identifies patient-specific foods that may be triggering IBS symptoms. By measuring immune responses above the normal level to a clinically defined panel of common foods, the test helps healthcare providers deliver personalized dietary therapy guidance—offering a targeted alternative to trial-and-error diets and symptom-masking medications.

IBS affects an estimated 10% to 15% of adults in the U.S. and is associated with up to $10 billion in direct annual medical costs. inFoods® IBS addresses this substantial unmet need by offering a scientifically validated, non-invasive tool to improve symptom control and enhance quality of life for patients.

Clinical Trial Data and Commercial Momentum

Results from a randomized, controlled clinical trial published in the June 2025 issue of Gastroenterology, the leading journal in the field, showed that patients who followed a diet based on inFoods® test results experienced significantly greater symptom reduction than those on a placebo diet. These data provide strong clinical validation of the test’s effectiveness and value.

The inFoods® IBS test is currently available through leading gastroenterology practices and is also offered directly to consumers via www.inFoodsIBS.com, enabling broader access through both traditional and self-pay channels.

Positioned for Long-Term Value Creation

The issuance of the PLA code for inFoods® IBS improves transparency in the reimbursement of this innovative test, supporting the Company’s mission to deliver personalized, non-drug solutions for chronic conditions. As insurance coverage is enabled and clinical evidence grows, inFoods® IBS is poised to become an important tool in the treatment and management of IBS and related gastrointestinal disorders.

Biomerica’s inFoods® platform continues to represent a scalable opportunity for innovation in GI care—driving better outcomes for patients and delivering value for healthcare providers and shareholders alike.

About Biomerica (NASDAQ:

BMRA

)

Biomerica, Inc. (www.biomerica.com or www.inFoodsIBS.com) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company’s products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica primarily focuses on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development. For more information, visit www.inFoodsIBS.com and www.biomerica.com.

About inFoods®

inFoods® IBS is a diagnostic-guided therapy that identifies patient-specific food triggers responsible for symptoms such as abdominal pain, bloating, diarrhea, and constipation. Using a simple finger-stick blood sample, the test enables physicians to recommend targeted dietary changes tailored to the patient’s immune response—offering a non-pharmaceutical, precision-based approach to symptom relief.

A multicenter, double-blind clinical study on the inFoods® IBS test was published in the June 2025 issue of Gastroenterology, the top peer-reviewed GI journal. As the largest study of its kind, it demonstrated statistically significant outcomes:

  • 59.6% of patients in the treatment group (who eliminated identified trigger foods) achieved the FDA’s endpoint for abdominal pain reduction, compared to 42.2% in the control group.
  • Among IBS-C patients, 67.1% of patients in the treatment group vs. 35.8% in the control group.
  • Among IBS-M patients, 66% of patients in the treatment group vs. 29.5% in the control group.

These results highlight inFoods® IBS as the only targeted therapy to demonstrate efficacy specifically in IBS-M patients, a subgroup historically underserved by existing treatments. The study was conducted at leading U.S. institutions including Cleveland Clinic, Mayo Clinic, University of Michigan, and Beth Israel Deaconess Medical Center.

For more information about inFoods® IBS, visit www.inFoodsIBS.com.

inFoods® IBS is a Laboratory Developed Test (LDT) used within a single laboratory that is certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing.

Forward Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by Biomerica) contains statements that are forward-looking, such as statements relating to the Company applying for a PLA code for the inFoods® IBS product, and the future possibility of inFoods® IBS receiving insurance reimbursement from Medicare or other insurers, the importance of the inFoods test in IBS, the Company’s current and future sales, revenues, overhead, expenses, cost of goods, operations and earnings, efficacy of the Company’s products and tests, FDA and/or international regulatory authorization for the Company’s products to be marketed and sold, including the inFoods® IBS product, and the Company’s other current and future products, the possible expansion in to other markets, uniqueness of the Company’s products, accuracy of the Company’s tests and products, expected completion of clinical studies, pricing of the Company’s test kits, domestic and/or international market adoption and acceptance and demand for the Company’s products, future use of the Company’s products by physicians to treat their patients, potential revenues from the sale of current or future products. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results, in the future, including, without limitation: earnings and other financial results; results of studies testing the efficacy of the Company’s inFoods® tests and other products; regulatory approvals necessary prior to commercialization of the Company’s products; availability of the Company’s test kits and other products; capacity, shipping logistics, resource and other constraints on our suppliers; dependence on our third party manufacturers; dependence on international shipping carriers; governmental import/export regulations; demand for our various tests and other products; competition from other similar products and from competitors that have significantly more financial and other resources available to them; governmental virus control regulations that make it difficult or impossible for the company to maintain current operations; regulatory compliance and oversight, and the Company’s ability to obtain patent protection on any aspects of its diagnostic or therapeutic technologies. Accordingly, such results may differ materially from those expressed in any forward-looking statements made by or on behalf of Biomerica. Additionally, potential risks and uncertainties include, among others, fluctuations in the Company’s operating results due to its business model and expansion plans, downturns in international and or national economies, the Company’s ability to raise additional capital, the competitive environment in which the Company will be competing, and the Company’s dependence on strategic relationships. The Company is under no obligation to update any forward-looking statements after the date of this release.

Corporate Contact:

Zack Irani
949-645-2111
[email protected]

Source: Biomerica, Inc.



Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

ORLANDO, Fla., July 02, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) (“Nutriband” or the “Company”) announced today that its Board of Directors has approved and declared a 25% preferred stock dividend.

Shareholders of record on July 25th 2025 will receive one preferred share for every four shares of common stock held. The pay date for shareholders to receive their new issuance will be August 5th.

Each preferred share will be convertible to one share of common stock following FDA approval of the Company’s AVERSA Fentanyl product.

If the preferred share remains unconverted it shall be entitled to a cash dividend paid from the profits of the company on an annual basis as decided by the board of Directors.

“Our core goal is to continue to create value for our shareholders particularly as we near closer to the commercialization of AVERSA fentanyl. We recently highlighted our Commercialization manufacturing process scale up with Kindeva and we are now laser focused on finalizing our development pathway to FDA approval,” said Gareth Sheridan, CEO.

About AVERSA™ Abuse-Deterrent Transdermal Technology

Nutriband’s AVERSA™ abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. The AVERSA™ abuse-deterrent technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to those patients who really need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia.

About Nutriband Inc.

We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA™ abuse-deterrent technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

The Company’s website is www.nutriband.com. Any material contained in or derived from the Company’s websites or any other website is not part of this press release.

Forward-Looking Statements

Certain statements contained in this press release, including, without limitation, statements containing the words ‘’believes,” “anticipates,” “expects” and words of similar import, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company’s actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company’s ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company’s business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Form S-1, Forms 10-K’s and Forms 10-Q’s, and the Company’s other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.

Contact Information:
Nutriband Inc.
Phone: 407-377-6695
Email: [email protected]
SOURCE: Nutriband Inc.



Mogo Announces $50 Million Bitcoin Treasury Authorization and Strategic Alignment with Bitcoin Across the Organization

Mogo Announces $50 Million Bitcoin Treasury Authorization and Strategic Alignment with Bitcoin Across the Organization

Board-Approved Allocation Reflects Long-Term Conviction in Bitcoin as a Strategic Reserve Asset and Foundation for Innovation Across Treasury and Product Strategy

Strategic Alignment Across Core Businesses of Wealth, Payments and Lending

Company Adopts Bitcoin as Corporate Hurdle Rate

VANCOUVER, British Columbia–(BUSINESS WIRE)–
Mogo Inc. (“Mogo” or the “Company”) (NASDAQ: MOGO; TSX: MOGO), a leading Canadian digital wealth and lending platform, today announced that its Board of Directors has authorized the allocation of up to $50 million to Bitcoin as part of the Company’s long-term capital preservation and product innovation strategy. The move marks a significant step in Mogo’s strategic alignment with Bitcoin, integrating it across treasury policy and its core operating platform.

Mogo has been at the forefront of digital asset innovation for nearly a decade. In 2018, it launched Canada’s first Bitcoin account, and in 2020, it became the third US-listed company to add Bitcoin to its balance sheet, following MicroStrategy and Block, and ahead of Tesla. Mogo also played a key role in the formation of Canada’s largest independent crypto platform through the 2023 merger of Coinsquare and WonderFi, which recently announced it has entered into an agreement to be acquired by Robinhood.

“Building on our history and experience in crypto, we’re making a long-term strategic commitment to Bitcoin, backed by deep conviction and the flexibility to build a meaningful Bitcoin reserve that aligns with our capital priorities and market outlook,” said Greg Feller, President & Co-Founder of Mogo. “This allocation gives us the flexibility to build a meaningful position over time as part of a disciplined, multi-year strategy.”

Board-Approved $50 Million Bitcoin Treasury Authorization

Following the anticipated close of the WonderFi–Robinhood transaction in the second half of 2025, Mogo expects to hold approximately $50 million in cash and investments. The Company’s Board has approved a Bitcoin allocation of up to $50 million, to be funded by excess cash on the balance sheet and, over time, through additional monetizations from its investment portfolio, including investments in US-based crypto exchange, Gemini, and Canadian technology company, Hootsuite.

The Company has an initial goal to scale to a $50 million investment in Bitcoin based on staged investments over time, while keeping adequate working capital for the operating business.

Bitcoin as a Hurdle Rate for Capital Allocation

In a move that signals deep integration of Bitcoin into its corporate framework, Mogo will now assess all capital deployment decisions against a Bitcoin hurdle rate. Whether considering M&A, internal investments, or share repurchases, the Company will only allocate capital to opportunities that are expected to outperform the long-term return profile of holding Bitcoin.

“This sets a new bar for capital discipline,” said Greg Feller. “If we don’t believe an initiative can deliver better long-term value than Bitcoin, we won’t pursue it. It’s that simple.”

This approach reinforces Bitcoin’s role not just as a treasury asset, but as a strategic benchmark for evaluating value creation across the organization.

A Dual-Compounding Strategy: Bitcoin Reserve + Operating Scale

Mogo’s approach is fundamentally different from most Bitcoin treasury companies. While many lack operating scale or growth potential, Mogo is building a capital-efficient, scalable platform across three core pillars; Wealth, Lending, and Payments, with Bitcoin serving as a complementary strategic reserve asset that can compound alongside its core business.

“We’re not just holding Bitcoin, we’re building a business we believe can scale to over a billion dollars in enterprise value,” said Greg Feller. “Our goal is to grow a similarly scaled Bitcoin reserve alongside it. That dual-compounding model, operating growth plus a high-conviction Bitcoin reserve, is something few companies are positioned to achieve.”

Strategic Integration Across the Platform

Bitcoin will be integrated across Mogo’s core businesses to deliver value to both shareholders and the Company’s nearly 2 million Canadian members:

  • Wealth Management: Mogo’s $400M+ AUM platform will launch a flagship Bitcoin Portfolio based on a 60/40 equity/Bitcoin model designed for long-term investors who understand Bitcoin’s role as a disruptive store of value.

  • Lending: Mogo is developing Bitcoin-related loan products that will allow all members to gain access to this asset class, while also potentially lowering their borrowing rates.

  • Payments: With over $12 billion in annual international payments volume, Mogo is exploring stablecoin infrastructure to enable faster, lower-cost cross-border transactions.

Buffett Mode Meets Bitcoin: A Behavioral Framework

Mogo’s approach is grounded in its Buffett-mode philosophy, a behavioral-first investment framework focused on long-term outcomes, mental clarity, and disciplined decision-making.

“Whether you’re investing in equities or Bitcoin, the edge is mental,” said David Feller, Founder & CEO of Mogo. “We’re not here to speculate, we’re here to help Canadians build real wealth. That means evaluating every decision with clarity and conviction, and giving our members access to tools that align with where the world is going, not where it’s been.”

Mogo offers educational content, product-level optionality, and behavioral guidance, not hype. Bitcoin is not promoted as a default solution but offered as a strategic asset for informed, intentional investors.

Democratizing Access to Bitcoin for 2 Million Canadians

Mogo is uniquely positioned to expand responsible access to Bitcoin through trusted, compliant, and intelligent financial products. The Company’s platform reflects a long-term belief in digital assets as a tool for wealth preservation, not short-term speculation.

“This is about building financial independence for our members, not chasing returns,” added Greg Feller. “We believe Bitcoin will play a growing role in how capital is stored, allocated, and judged, and we’re building Mogo to lead in that future.”

About Mogo

Mogo Inc. (NASDAQ:MOGO; TSX:MOGO) is a financial technology company with three distinct business lines: wealth, lending, and payments. Our mission is to provide consumers with innovative financial solutions that drive long-term financial health and success. We operate with a differentiated approach in each business, leveraging technology, behavioral science, and financial tools to create unique value propositions in our respective markets.

Our wealth and lending businesses are focused on the Canadian market, where we are the only subprime consumer lender that also offers a holistic wealth and investing solution. This unique integration is designed to help consumers transition from borrowing and debt to long-term wealth building. Separately, our payments business is operated through Carta Worldwide, a wholly owned subsidiary that provides modern card issuing and processing solutions, primarily in Europe.

Forward-Looking Statements

This news release may contain “forward-looking statements” within the meaning of applicable securities legislation, including statements regarding the expected closing of the WonderFi-Robinhood transaction, Mogo’s Bitcoin treasury strategy, Mogo’s capital allocation strategy, Mogo’s strategic initiatives in respect of its wealth management, lending and payment products and the integration of cryptocurrency in respect thereof. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at the time of preparation, are inherently subject to significant business, economic and competitive uncertainties and contingencies, and may prove to be incorrect. Forward-looking statements are typically identified by words such as “may”, “will”, “could”, “would”, “anticipate”, “believe”, “expect”, “intend”, “potential”, “estimate”, “budget”, “scheduled”, “plans”, “planned”, “forecasts”, “goals” and similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. Mogo’s growth, its ability to expand into new products and markets and its expectations for its future financial performance are subject to a number of conditions, including receipt of applicable regulatory approvals in respect of its products, many of which are outside of Mogo’s control. For a description of the risks associated with Mogo’s business please refer to the “Risk Factors” section of Mogo’s current annual information form, which is available at www.sedarplus.com and www.sec.gov. Except as required by law, Mogo disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.

Investor Relations

[email protected]

US Investor Relations Contact

Lytham Partners, LLC

Ben Shamsian

New York | Phoenix

[email protected]

(646) 829-9701

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Cryptocurrency Payments Finance Asset Management Professional Services Technology Fintech Digital Cash Management/Digital Assets

MEDIA:

Saying yes to pets pays off for landlords

PR Newswire

Renters with pets are on the rise, and Zillow data shows listings that welcome them rent faster

  • Rental listings on Zillow that allow pets are typically leased eight days faster.
  • Fifty-eight percent of renters have pets, up from 46% in 2019.
  • Austin, Dallas and San Antonio had the highest share of pet-friendly rental listings on Zillow last year.


SEATTLE
, July 2, 2025 /PRNewswire/ — Saying yes to Fido or Mittens can help landlords lease faster. Pet-friendly rentals draw more views, saves and shares, and they are typically snapped up eight days sooner. That’s according to a new analysis of more than 11 million rental listings on Zillow® last year.

Renters are getting older, and they are more likely to have pets as they settle into long-term renting. Nearly 6 in 10 renters have a pet, up from 46% before the pandemic. Almost half say they passed on a particular property because it was not pet-friendly.

“Allowing pets can be a strategic edge for landlords competing to fill units,” said Emily McDonald, Zillow rental trends expert. “Today’s renters are more established and more likely to have a pet, and we clearly see that pet-friendly rentals attract more interest on Zillow. In a market where renters have more options, allowing pets can make the difference in finding a tenant quickly.”

Last year, 57% of rental listings on Zillow Rentals, the rental network with more listings than any other,1 allowed pets. On average, those listings earned 9% more views, 12% more saves and 11% more shares than those that did not allow pets. They were also typically rented out eight days faster.

Texas has a claim as the most pet-friendly state, with Austin (80%), Dallas (79%) and San Antonio (78%) leading all major metro areas in the share of pet-friendly rental listings on Zillow last year. However, nationwide, Houston had the smallest share of rental listings that allowed pets, at just 38%. Also near the bottom were Providence (43%), Hartford (43%) and San Jose (44%).

Pet-friendly rentals in the New York City metro area typically rented 26 days faster than units that did not accept pets, the biggest gap of any major market. Tampa (16 days), Columbus (12 days), Phoenix (11 days), Cincinnati (10 days) and Austin (10 days) also saw pet-friendly listings rented out at least 10 days faster. 

The boost in renter engagement for pet-friendly listings held true nearly across the board among major markets. New York was the only holdout, seeing 2% more saves for pet-friendly units, but 2% fewer views and shares. This is likely because these listings spent 26 fewer days on the market, giving them less time to rack up engagement numbers.


Metro Area*


Share of Pet-Friendly
Rental Listings


Median Days Faster for Pet-Friendly Rentals
to Find a Tenant

United States

57 %

8

New York, NY

53 %

26

Los Angeles, CA

52 %

6

Chicago, IL

60 %

0

Dallas, TX

79 %

3

Houston, TX

38 %

1

Washington, DC

58 %

4

Philadelphia, PA

59 %

4

Miami, FL

51 %

9

Atlanta, GA

68 %

4

Boston, MA

51 %

9

Phoenix, AZ

70 %

11

San Francisco, CA

49 %

5

Riverside, CA

54 %

2

Detroit, MI

48 %

6

Seattle, WA

70 %

1

Minneapolis, MN

70 %

4

San Diego, CA

59 %

4

Tampa, FL

71 %

16

Denver, CO

77 %

0

Baltimore, MD

53 %

2

St. Louis, MO

63 %

2

Orlando, FL

67 %

2

Charlotte, NC

72 %

4

San Antonio, TX

78 %

6

Portland, OR

67 %

2

Sacramento, CA

55 %

0

Pittsburgh, PA

50 %

3

Cincinnati, OH

62 %

10

Austin, TX

80 %

10

Las Vegas, NV

45 %

3

Kansas City, MO

76 %

0

Columbus, OH

65 %

12

Indianapolis, IN

70 %

6

Cleveland, OH

50 %

4

San Jose, CA

44 %

3

Nashville, TN

77 %

5

Virginia Beach, VA

58 %

3

Providence, RI

43 %

3

Jacksonville, FL

71 %

8

Milwaukee, WI

52 %

1

Oklahoma City, OK

72 %

5

Raleigh, NC

72 %

8

Memphis, TN

67 %

6

Richmond, VA

67 %

5

Louisville, KY

60 %

2

New Orleans, LA

52 %

6

Salt Lake City, UT

58 %

-3

Hartford, CT

43 %

-7

Buffalo, NY

47 %

-6

Birmingham, AL

67 %

4


*Table ordered by market size 

About Zillow Group
Zillow Group, Inc. (Nasdaq: Z and ZG) is reimagining real estate to make home a reality for more and more people. As the most visited real estate app and website in the United States, Zillow and its affiliates help people find and get the home they want by connecting them with digital solutions, dedicated real estate professionals, and easier buying, selling, financing, and renting experiences.

Zillow Group’s affiliates, subsidiaries and brands include Zillow®, Zillow Premier Agent®, Zillow Home Loans℠, Zillow Rentals®, Trulia®, Out East®, StreetEasy®, HotPads®, ShowingTime+℠, Spruce®, and Follow Up Boss®.

All marks herein are owned by MFTB Holdco, Inc., a Zillow affiliate. Zillow Home Loans, LLC is an Equal Housing Lender, NMLS #10287 (www.nmlsconsumeraccess.org). © 2025 MFTB Holdco, Inc., a Zillow affiliate.

1 Zillow internal data on total rental properties compared to Apartments.com data published on its website and investor materials, March 2025.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/saying-yes-to-pets-pays-off-for-landlords-302496464.html

SOURCE Zillow

Stellantis to Announce First Half 2025 Results on July 29

Stellantis to Announce First Half 2025 Results on July 29

AMSTERDAM, July 2, 2025 – Stellantis N.V. announced today that its First Half 2025 Results will be released on Tuesday, July 29, 2025.

A live webcast and conference call of the First Half 2025 Results will begin at 2 p.m. CEST / 8 a.m. EDT on Tuesday, July 29, 2025.

The related press release and presentation material are expected to be posted under the Investors section of the Stellantis corporate website (www.stellantis.com) at approximately 8 a.m. CEST / 2 a.m. EDT on Tuesday, July 29, 2025.

Details for accessing this presentation are available under the Investors section of the Stellantis corporate website. For those unable to participate in the live session, a recorded replay will be accessible following the event.

# # #


About Stellantis

Stellantis N.V. (NYSE: STLA / Euronext Milan: STLAM / Euronext Paris: STLAP) is a leading global automaker, dedicated to giving its customers the freedom to choose the way they move, embracing the latest technologies and creating value for all its stakeholders. Its unique portfolio of iconic and innovative brands includes Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, FIAT, Jeep

®

, Lancia, Maserati, Opel, Peugeot, Ram, Vauxhall, Free2move and Leasys. For more information, visit www.stellantis.com.

@Stellantis Stellantis Stellantis Stellantis

For more information, contact:

Fernão SILVEIRA +31 6 43 25 43 41 – [email protected]

Nathalie ROUSSEL +33 6 87 77 41 82 – [email protected]

[email protected]
www.stellantis.com

 

Attachment



Microchip Partners with Nippon Chemi-Con and NetVision on First ASA-ML Camera Development Ecosystem for Japanese Automotive Market

Ecosystem’s camera module and development tools are based on Microchip’s VS700 family of serializers and deserializers and will help Japanese OEMs speed ASA-ML adoption in ADAS applications

CHANDLER, Ariz., July 02, 2025 (GLOBE NEWSWIRE) — An automotive industry transition is underway to replace proprietary camera connectivity with solutions based on the open and interoperable Automotive Serdes Alliance Motion Link (ASA-ML) standard driven by over 150 member companies worldwide. To simplify and accelerate the adoption of ASA-ML for Advanced Driver-Assistance Systems (ADAS), Microchip Technology (Nasdaq: MCHP) has partnered with camera module supplier Nippon Chemi-Con Corporation and video-testing solution provider NetVision Co. Ltd. to deliver the first ASA-ML camera-development platform of its kind that brings the standard’s scalable high-speed asymmetric data rates to the Japanese automotive market while supporting critical hardware-based link-layer security to meet emerging automotive cybersecurity regulations.

“We were first to market with an ASA-ML chipset through our acquisition of VSI, and now we have collaborated with pioneers like Nippon Chemi-Con and NetVision to deliver the first camera development ecosystem that reduces risk and speeds ASA-ML adoption for Japanese OEMs,” said Kevin So, vice president of Microchip’s communications business unit. “Nippon Chemi-Con’s CDTrans camera module and NetVision’s NV061 development emulation board are both based on our VS775S single-port serializer/deserializer device, further demonstrating the industry’s commitment to a standardized ASA-ML solution for Japanese automotive OEMs as they embrace the rapid growth of camera-based ADAS systems driven by the need for safety and convenience.”

“We are excited to collaborate with an automotive semiconductor market leader like Microchip in offering Japanese OEMs another important first with our new CDTrans ASA-ML-based automotive camera module that is integrated with the VS775S serializer,” said Katsunori Nogami, managing executive officer, chief technology officer with Nippon Chemi-Con. “We recognize the importance and benefit of open standards-based connectivity technologies like ASA-ML that automotive Tier 1 suppliers and OEMs need for interoperable multi-vendor solutions. This collaboration is a key step in accelerating ASA-ML adoption for next-generation ADAS camera systems in Japan’s rapidly evolving SDV landscape. Combined with NetVision’s well recognized camera test and emulation platform, our camera module will enable cross-vendor compatibility, future-proof scalability, and a pathway beyond closed systems.”

“Partnering with Microchip and Nippon Chemi-Con on this new ASA-ML ecosystem platform will help realize a standardized and scalable electrical/electronic in-vehicle networking architecture for Japan’s SDV era,” said Kenji Kudo, Ph.D., engineering department director at NetVision. “Our development of a VS775S based ASA-ML serializer connection board coupled to our unique camera emulation development platform for ADAS ECUs will help remove a key barrier to adoption for many Japanese OEMs and Tier 1s who have been hampered by proprietary connectivity protocols that limit interoperability and scalability. We look forward to continued collaboration on advancing the ASA-ML ecosystem.”

Industry leaders including BMW, Ford, Volvo, GM, Continental, Bosch, Denso and Microchip and numerous other semiconductor companies are among the dozens of ASA-ML members helping to industrialize and promote ASA-ML adoption. These and other member companies represent the complete automotive ecosystem, including car manufacturers, Tier 1 suppliers, semiconductor vendors, cable and connector manufacturers, test tool vendors, and test houses. OEMs adopting camera solutions based on a new standard like ASA-ML require development tools, emulation platforms and broad supply chain support.



Microchip’s VS775S

single port ASA-ML serializer/deserializer solves this problem through its standards-compliant, asymmetric and scalable-bandwidth video support that enables Nippon Chemi-Con to create an ecosystem-ready camera module for the Japanese automotive market. The camera emulation and development platform from NetVision also takes advantage of the Microchip VS775S to further simplify development and verification by enabling efficient evaluation of video signal quality during the design of camera modules and Engine Control Units (ECUs). The platform enables video signals to be captured in real-time leveraging Microchip’s VS775S evaluation board.

Multi-vendor solutions have become a critical priority for managing supply-chain risk across the automotive industry. OEMs and Tier 1 suppliers seek greater sourcing flexibility and long-term operational resilience. This is especially true for L2 and L2+ autonomous-level applications, which are integrating an increasing number of cameras and sensors into vehicles. These trends further amplify the need for scalable, architecturally flexible, interoperable, multi-vendor and high-bandwidth connectivity solutions that eliminate the shortcomings of closed, single-vendor ecosystems in an evolving landscape.

Microchip will be demonstrating this camera/capture card at the Automotive Ethernet Tech Days, Kyoto International Conference Center Annex Hall, Kyoto, Japan, July 3-4.

Pricing and Availability

Engineering samples of the VS775S serializer/deserializer and evaluation kits are available to qualified customers today. For additional information, contact a Microchip sales representative or authorized worldwide distributor or visit Microchip’s website, www.microchip.com/asa.

Resources

High-res images available through Flickr or editorial contact (feel free to publish):
• PR image: www.flickr.com/photos/microchiptechnology/54577687622/sizes/o/


About Microchip Technology

:

Microchip Technology Inc. is a leading provider of smart, connected and secure embedded control and processing solutions. Its easy-to-use development tools and comprehensive product portfolio enable customers to create optimal designs which reduce risk while lowering total system cost and time to market. The company solutions serve more than 100,000 customers across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support along with dependable delivery and quality. For more information, visit the Microchip website at www.microchip.com.

Note: The Microchip name and logo and the Microchip logo are registered trademarks of Microchip Technology Incorporated in the U.S.A. and other countries. All other trademarks mentioned herein are the property of their respective companies.

Editorial Contact: Reader Inquiries:
Brian Thorsen 1-888-624-7435
480-792-7182  


[email protected]

 



UniFirst Announces Financial Results for the Third Quarter of Fiscal 2025

WILMINGTON, Mass., July 02, 2025 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its third quarter ended May 31, 2025 as compared to the corresponding period in the prior fiscal year:

Q3 2025 Financial Highlights

  • Consolidated revenues for the third quarter increased 1.2% to $610.8 million.
  • Operating income was $48.2 million, a decrease of 0.6%.
  • The quarterly tax rate increased to 25.7% compared to 22.9% in the prior year.
  • Net income increased to $39.7 million from $38.1 million in the prior year, or 4.3%.
  • Diluted earnings per share increased to $2.13 from $2.03 in the prior year, or 4.9%.
  • Adjusted EBITDA increased to $85.8 million compared to $84.8 million in the prior year, or 1.2%.

The Company’s financial results for the third quarter of fiscal 2025 and 2024 included approximately $1.0 million and $3.9 million, respectively, of costs directly attributable to its customer relationship management (“CRM”) computer system and enterprise resource planning (“ERP”) projects. The Company refers to the CRM and ERP projects together as its “Key Initiatives”. The effect of these items on the third quarter of fiscal 2025 and 2024 combined to decrease:

  • Operating income and Adjusted EBITDA by $1.0 million and $3.9 million, respectively.
  • Net income by $0.7 million and $2.9 million, respectively.
  • Diluted earnings per share by $0.04 and $0.16, respectively.

Net income and diluted earnings per share also benefited from a $2.8 million gain on the sale of a non-operating property during the quarter. This gain was recorded to other (income) expense, net, but was excluded from Adjusted EBITDA.

Steven Sintros, UniFirst President and Chief Executive Officer, said, “The results for our third quarter were largely in line with our expectations. It is rewarding to see our recent investments beginning to yield measurable returns, evidenced by gross margin improvement and more effective execution across the business. I want to sincerely thank all of our Team Partners who continue to Always Deliver for each other and our customers as we strive towards our vision of being universally recognized as the best service provider in the industry. …all while living our mission of Serving the People Who do the Hard Work.

Segment Reporting Highlights

Core Laundry Operations

  • Revenues for the quarter increased 0.9% to $533.2 million.
  • Organic growth, which excludes the effect of acquisitions and fluctuations in the Canadian dollar, was 1.1%.
  • Operating margin decreased to 6.9% from 7.0%.
  • Adjusted Core Laundry Operations’ EBITDA margin was unchanged at 13.5%.

The costs we incurred related to the Key Initiatives were recorded to the Core Laundry Operations’ segment, and decreased both the Core Laundry Operations’ operating and Adjusted EBITDA margins for the third quarters of fiscal 2025 and 2024 by 0.2% and 0.7%, respectively.

The segment’s operating and Adjusted EBITDA margins in the third quarter of fiscal 2025 were relatively consistent with the third quarter of the prior fiscal year. Both margin comparisons to the prior year continued to benefit from lower merchandise and production costs as a percentage of revenue but were offset by higher healthcare claims expense and approximately $5.7 million of expense related to advisory costs for a strategic matter and legal costs related to an employee matter in the third quarter of fiscal 2025.

Balance Sheet and Capital Allocation

  • Cash, cash equivalents and short-term investments totaled $211.9 million as of May 31, 2025.
  • Cash flows from operating activities were $196.5 million in the first nine months of fiscal 2025.
  • The Company repurchased $13.6 million of shares of Common Stock in the third quarter of fiscal 2025 and as of May 31, 2025 had $86.4 million remaining under its existing share repurchase authorization.

Financial Outlook

Mr. Sintros continued, “We are currently maintaining our annual revenue guidance within the range of $2.422 billion to $2.432 billion. However, we are raising our diluted earnings per share guidance to a range of $7.60 to $8.00. This adjustment reflects an updated assumption that our Key Initiative costs in fiscal 2025 will be approximately $7.5 million, revised from our previous estimate.”

Please remember that fiscal year 2025 will consist of one less week of operations compared to fiscal year 2024, which included an additional week in its fourth fiscal quarter. Also, the guidance does not assume future share buybacks or unforeseen economic events.

Conference Call Information

UniFirst Corporation will hold a conference call today at 9:00 a.m. (ET) to discuss its quarterly financial results, business highlights and outlook. A simultaneous live webcast of the call will be available over the Internet and can be accessed at www.unifirst.com.

About UniFirst Corporation

Headquartered in Wilmington, Mass., UniFirst Corporation (NYSE: UNF) is a North American leader in the supply and servicing of uniform and workwear programs, facility service products, as well as first aid and safety supplies and services. Together with its subsidiaries, the Company also manages specialized garment programs for the cleanroom and nuclear industries. In addition to partnering with leading brands, UniFirst manufactures its own branded workwear, protective clothing, and floorcare products at its five company-owned ISO-9001-certified manufacturing facilities. With more than 270 service locations, over 300,000 customer locations, and 16,000-plus employee Team Partners, the Company outfits more than 2 million workers every day. For more information, contact UniFirst at 888.296.2740 or visit UniFirst.com.

Forward-Looking Statements Disclosure

This public announcement contains forward-looking statements within the meaning of the federal securities laws that reflect the Company’s current views with respect to future events and financial performance, including projected revenues, operating margin and earnings per share. Forward-looking statements contained in this public announcement are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995 and may be identified by words such as “guidance,” “outlook,” “estimates,” “anticipates,” “projects,” “plans,” “expects,” “intends,” “believes,” “seeks,” “could,” “should,” “may,” “will,” “strategy,” “objective,” “assume,” “strive,” “design,” “assumption,” “vision,” “approximate,” or the negative versions thereof, and similar expressions and by the context in which they are used. Such forward-looking statements are based upon our current expectations and speak only as of the date made. Such statements are highly dependent upon a variety of risks, uncertainties and other important factors that could cause actual results to differ materially from those reflected in such forward-looking statements. Such factors include, but are not limited to, uncertainties caused by an economic recession or other adverse economic conditions, including, without limitation, as a result of elevated inflation or interest rates or extraordinary events or circumstances such as geopolitical conflicts like the conflict between Russia and Ukraine and disruption in the Middle East, and their impact on our customers’ businesses and workforce levels, disruptions of our business and operations, including limitations on, or closures of, our facilities, or the business and operations of our customers or suppliers in connection with extraordinary events or circumstances uncertainties regarding our ability to consummate acquisitions and successfully integrate acquired businesses, and the performance of such businesses, uncertainties regarding any existing or newly-discovered expenses and liabilities related to environmental compliance and remediation, any adverse outcome of pending or future contingencies or claims, our ability to compete successfully without any significant degradation in our margin rates, seasonal and quarterly fluctuations in business levels, our ability to preserve positive labor relationships and avoid becoming the target of corporate labor unionization campaigns that could disrupt our business, the effect of currency fluctuations on our results of operations and financial condition, our dependence on third parties to supply us with raw materials, which such supply could be severely disrupted as a result of extraordinary events or circumstances such as the conflict between Russia and Ukraine, any loss of key management or other personnel, increased costs as a result of any changes in federal, state, international or other laws, rules and regulations or governmental interpretation of such laws, rules and regulations, uncertainties regarding, or adverse impacts from continued high price levels of natural gas, electricity, fuel and labor or increases in such costs, the negative effect on our business from sharply depressed oil and natural gas prices, the continuing increase in domestic healthcare costs, increased workers’ compensation claim costs, increased healthcare claim costs, our ability to retain and grow our customer base, demand and prices for our products and services, fluctuations in our Specialty Garments business, political or other instability, supply chain disruption or infection among our employees in Mexico and Nicaragua where our principal garment manufacturing plants are located, our ability to properly and efficiently design, construct, implement and operate a new enterprise resource planning computer system, interruptions or failures of our information technology systems, including as a result of cyber-attacks, additional professional and internal costs necessary for compliance with any changes in or additional Securities and Exchange Commission (the “SEC”), New York Stock Exchange and accounting or other rules, strikes and unemployment levels, our efforts to evaluate and potentially reduce internal costs, the impact of foreign trade policies and tariffs or other impositions on imported goods on our business, results of operations and financial condition, our ability to successfully implement our business strategies and processes, including our capital allocation strategies, our ability to successfully remediate the material weaknesses in internal control over financial reporting disclosed in our Annual Report on Form 10-K for the year ended August 31, 2024 and the other factors described under Part I, Item 1A. “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended August 31, 2024, Part II, Item 1A. “Risk Factors” and elsewhere in our subsequent Quarterly Reports on Form 10-Q and in our other filings with the SEC. We undertake no obligation to update any forward-looking statements to reflect events or circumstances arising after the date on which they are made.

Consolidated Statements of Income


(Unaudited)

    Thirteen Weeks Ended     Thirty-Nine Weeks Ended  
(In thousands, except per share data)   May 31, 2025     May 25, 2024     May 31, 2025     May 25, 2024  
Revenues   $ 610,778     $ 603,328     $ 1,817,905     $ 1,787,564  
                         
Operating expenses:                        
Cost of revenues (1)     385,189       391,244       1,160,388       1,171,231  
Selling and administrative expenses (1)     142,690       129,074       418,119       383,350  
Depreciation and amortization     34,722       34,560       104,476       103,453  
Total operating expenses     562,601       554,878       1,682,983       1,658,034  
                         
Operating income     48,177       48,450       134,922       129,530  
                         
Other (income) expense:                        
Interest income, net     (2,514 )     (1,406 )     (7,422 )     (4,590 )
Other (income) expense, net     (2,704 )     522       (1,620 )     1,813  
Total other income, net     (5,218 )     (884 )     (9,042 )     (2,777 )
                         
Income before income taxes     53,395       49,334       143,964       132,307  
Provision for income taxes     13,715       11,277       36,720       31,468  
                         
Net income   $ 39,680     $ 38,057     $ 107,244     $ 100,839  
                         
Income per share – Basic:                        
Common Stock   $ 2.22     $ 2.12     $ 6.01     $ 5.61  
Class B Common Stock   $ 1.78     $ 1.70     $ 4.80     $ 4.49  
                         
Income per share – Diluted:                        
Common Stock   $ 2.13     $ 2.03     $ 5.76     $ 5.38  
                         
Income allocated to – Basic:                        
Common Stock   $ 33,346     $ 31,962     $ 90,126     $ 84,716  
Class B Common Stock   $ 6,334     $ 6,095     $ 17,118     $ 16,123  
                         
Income allocated to – Diluted:                        
Common Stock   $ 39,680     $ 38,057     $ 107,244     $ 100,839  
                         
Weighted average shares outstanding – Basic:                        
Common Stock     14,990       15,062       15,007       15,094  
Class B Common Stock     3,557       3,590       3,563       3,590  
                         
Weighted average shares outstanding – Diluted:                        
Common Stock     18,607       18,705       18,633       18,738  
 

(1) Exclusive of depreciation on the Company’s property, plant and equipment and amortization on its intangible assets.

Condensed Consolidated Balance Sheets


(Unaudited)

(In thousands)   May 31, 2025     August 31, 2024  
Assets            
Current assets:            
Cash and cash equivalents   $ 211,910     $ 161,571  
Short-term investments           13,505  
Receivables, net     281,815       278,851  
Inventories     148,847       156,908  
Rental merchandise in service     227,580       237,969  
Prepaid taxes     12,133       14,893  
Prepaid expenses and other current assets     55,589       51,979  
Total current assets     937,874       915,676  
Property, plant and equipment, net     817,931       801,612  
Goodwill     653,300       648,850  
Customer contracts and other intangible assets, net     107,282       119,999  
Deferred income taxes     851       833  
Operating lease right-of-use assets, net     72,461       66,682  
Other assets     170,328       142,761  
Total assets   $ 2,760,027     $ 2,696,413  
Liabilities and shareholders’ equity            
Current liabilities:            
Accounts payable   $ 76,395     $ 92,509  
Accrued liabilities     172,719       170,240  
Accrued taxes           447  
Operating lease liabilities, current     17,835       18,241  
Total current liabilities     266,949       281,437  
Long-term liabilities:            
Accrued liabilities     124,366       123,401  
Accrued and deferred income taxes     137,029       132,496  
Operating lease liabilities     56,892       50,568  
Total liabilities     585,236       587,902  
Shareholders’ equity:            
Common Stock     1,494       1,500  
Class B Common Stock     355       359  
Capital surplus     108,486       104,791  
Retained earnings     2,088,873       2,025,505  
Accumulated other comprehensive loss     (24,417 )     (23,644 )
Total shareholders’ equity     2,174,791       2,108,511  
Total liabilities and shareholders’ equity   $ 2,760,027     $ 2,696,413  
 



Detail of Operating Results


(Unaudited)

    Thirteen Weeks Ended May 31, 2025     Thirteen Weeks Ended May 25, 2024  
    Core
Laundry
  Specialty   First         Core
Laundry
  Specialty   First      
(In thousands, except percentages)   Operations   Garments   Aid   Total     Operations   Garments   Aid   Total  
Revenues   $ 533,188   $ 47,803   $ 29,787   $ 610,778     $ 528,454   $ 47,582   $ 27,292   $ 603,328  
Revenue Growth %     0.9 %   0.5 %   9.1 %   1.2 %                  
                                     
Operating Income (1), (2)   $ 36,737   $ 10,915   $ 525   $ 48,177     $ 36,929   $ 11,373   $ 148   $ 48,450  
Operating Margin     6.9 %   22.8 %   1.8 %   7.9 %     7.0 %   23.9 %   0.5 %   8.0 %
                                     
Adjusted EBITDA (1), (2)   $ 71,894   $ 12,402   $ 1,530   $ 85,826     $ 71,257   $ 12,552   $ 982   $ 84,791  
Adjusted EBITDA Margin     13.5 %   25.9 %   5.1 %   14.1 %     13.5 %   26.4 %   3.6 %   14.1 %
 

(1) The Company’s financial results for the third quarter of fiscal 2025 and 2024 included approximately $1.0 million and $3.9 million, respectively, of costs directly attributable to its Key Initiatives.
(2) The Key Initiatives’ costs decreased both Core Laundry Operations’ operating margin and Adjusted EBITDA margin for the third quarter of fiscal 2025 and 2024 by 0.2% and 0.7%, respectively.

 
    Thirty-Nine Weeks Ended May 31, 2025     Thirty-Nine Weeks Ended May 25, 2024  
    Core
Laundry
  Specialty   First         Core
Laundry
  Specialty   First      
(In thousands, except percentages)   Operations   Garments   Aid   Total     Operations   Garments   Aid   Total  
Revenues   $ 1,596,282   $ 138,160   $ 83,463   $ 1,817,905     $ 1,574,863   $ 135,713   $ 76,988   $ 1,787,564  
Revenue Growth %     1.4 %   1.8 %   8.4 %   1.7 %                  
                                     
Operating Income (Loss) (3), (4)   $ 104,027   $ 30,515   $ 380   $ 134,922     $ 98,066   $ 33,391   $ (1,927 ) $ 129,530  
Operating Margin     6.5 %   22.1 %   0.5 %   7.4 %     6.2 %   24.6 %   -2.5 %   7.2 %
                                     
Adjusted EBITDA (3), (4)   $ 210,312   $ 35,119   $ 3,273   $ 248,704     $ 200,657   $ 36,983   $ 675   $ 238,315  
Adjusted EBITDA Margin     13.2 %   25.4 %   3.9 %   13.7 %     12.7 %   27.3 %   0.9 %   13.3 %
                                                     

(3) The Company’s financial results for the first nine months of fiscal 2025 and 2024 included approximately $5.4 million and $10.0 million, respectively, of costs directly attributable to its Key Initiatives.
(4) The Key Initiatives’ costs decreased both Core Laundry Operations’ operating margin and Adjusted EBITDA margin for the third quarter of fiscal 2025 and 2024 by 0.3% and 0.6%, respectively.

Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)   May 31, 2025     May 25, 2024  
Cash flows from operating activities:            
Net income   $ 107,244     $ 100,839  
Adjustments to reconcile net income to cash provided by operating activities:            
Depreciation and amortization (1)     104,476       103,453  
Share-based compensation     9,049       7,145  
Accretion on environmental contingencies     960       948  
Accretion on asset retirement obligations     602       721  
Deferred income taxes     3,514       4,048  
Gain on sale of property and equipment     (2,690 )      
Other     336       1,061  
Changes in assets and liabilities, net of acquisitions:            
Receivables, less reserves     (3,174 )     (5,288 )
Inventories     8,338       (13,101 )
Rental merchandise in service     10,018       5,308  
Prepaid expenses and other current assets and Other assets     (16,729 )     (11,518 )
Accounts payable     (16,668 )     (5,118 )
Accrued liabilities     (12,190 )     (3,212 )
Prepaid and accrued income taxes     3,395       7,726  
Net cash provided by operating activities     196,481       193,012  
             
Cash flows from investing activities:            
Acquisition of businesses, net of cash acquired     (5,374 )     (203 )
Capital expenditures, including capitalization of software costs     (109,823 )     (121,937 )
Purchases of investments     (14,734 )     (24,581 )
Maturities of investments     28,356       21,679  
Proceeds from sale of assets     3,115       749  
Net cash used in investing activities     (98,460 )     (124,293 )
             
Cash flows from financing activities:            
Proceeds from exercise of share-based awards     4       3  
Taxes withheld and paid related to net share settlement of equity awards     (4,357 )     (2,731 )
Repurchase of Common Stock     (25,593 )     (15,962 )
Payment of cash dividends     (18,402 )     (17,436 )
Net cash used in financing activities     (48,348 )     (36,126 )
             
Effect of exchange rate changes     666       210  
             
Net increase in cash and cash equivalents     50,339       32,803  
Cash and cash equivalents at beginning of period     161,571       79,443  
Cash and cash equivalents at end of period   $ 211,910     $ 112,246  
   

(1) Depreciation and amortization for the first nine months of fiscal 2025 and 2024 included approximately $12.7 million and $13.9 million, respectively, of non-cash amortization expense recognized on acquisition-related intangible assets.

Reconciliation of GAAP to Non-GAAP Financial Measures

The Company reports its consolidated financial results in accordance with generally accepted accounting principles (“GAAP”). To supplement the Company’s consolidated financial results in this press release, the Company also presents Adjusted EBITDA and Adjusted EBITDA margin, which are non-GAAP financial measures. The Company defines Adjusted EBITDA as net income before interest, income taxes, depreciation and amortization, further adjusted for share-based compensation expense and other items impacting the comparability of the Company’s underlying operating performance between periods. Adjusted EBITDA margin is defined as Adjusted EBITDA for a period divided by revenue for the same period.     

The Company believes these non-GAAP financial measures provide useful supplemental information regarding the performance of the Company and its segments to both management and investors. In addition, by excluding certain items, these non-GAAP financial measures enable management and investors to further evaluate the underlying operating performance of the Company.

Supplemental reconciliations of the Company’s consolidated net income on a GAAP basis to Adjusted EBITDA and Adjusted EBITDA margin, are presented in the following table. Investors are encouraged to review the reconciliations of the non-GAAP financial measures to their most directly comparable GAAP financial measures, which are provided below. Adjusted EBITDA and Adjusted EBITDA margin should be considered in addition to, and not as substitutes for, or in isolation from, measures prepared in accordance with GAAP.

The Company does not allocate its provision for income taxes to its business segments and as a result, presents it in a separate column in the following tables.

  Thirteen Weeks Ended May 31, 2025  
    Core Laundry     Specialty     First              
(In thousands, except percentages)   Operations     Garments     Aid     Other     Total  
Revenue   $ 533,188     $ 47,803     $ 29,787     $     $ 610,778  
                               
Net income   $ 41,955     $ 10,915     $ 525     $ (13,715 )   $ 39,680  
Provision for income taxes                       13,715       13,715  
Interest income, net     (2,514 )                       (2,514 )
Depreciation and amortization     32,442       1,305       975             34,722  
Share-based compensation expense     2,803       182       30             3,015  
Gain on the sale of a non-operating property     (2,792 )                       (2,792 )
Adjusted EBITDA   $ 71,894     $ 12,402     $ 1,530     $     $ 85,826  
Adjusted EBITDA Margin     13.5 %     25.9 %     5.1 %           14.1 %
 

  Thirteen Weeks Ended May 25, 2024  
    Core Laundry     Specialty     First              
(In thousands, except percentages)   Operations     Garments     Aid     Other     Total  
Revenue   $ 528,454     $ 47,582     $ 27,292     $     $ 603,328  
                               
Net income   $ 37,813     $ 11,373     $ 148     $ (11,277 )   $ 38,057  
Provision for income taxes                       11,277       11,277  
Interest income, net     (1,406 )                       (1,406 )
Depreciation and amortization     32,716       1,035       809             34,560  
Share-based compensation expense     2,134       144       25             2,303  
Adjusted EBITDA   $ 71,257     $ 12,552     $ 982     $     $ 84,791  
Adjusted EBITDA Margin     13.5 %     26.4 %     3.6 %           14.1 %
 

  Thirty-Nine Weeks Ended May 31, 2025  
    Core Laundry     Specialty     First              
(In thousands, except percentages)   Operations     Garments     Aid     Other     Total  
Revenue   $ 1,596,282     $ 138,160     $ 83,463     $     $ 1,817,905  
                               
Net income   $ 113,069     $ 30,515     $ 380     $ (36,720 )   $ 107,244  
Provision for income taxes                       36,720       36,720  
Interest income, net     (7,422 )                       (7,422 )
Depreciation and amortization     97,622       4,047       2,807             104,476  
Share-based compensation expense     8,406       557       86             9,049  
Gain on the sale of a non-operating property     (2,792 )                       (2,792 )
Executive transaction costs     1,429                         1,429  
Adjusted EBITDA   $ 210,312     $ 35,119     $ 3,273     $     $ 248,704  
Adjusted EBITDA Margin     13.2 %     25.4 %     3.9 %           13.7 %
 

  Thirty-Nine Weeks Ended May 25, 2024  
    Core Laundry     Specialty     First              
(In thousands, except percentages)   Operations     Garments     Aid     Other     Total  
Revenue   $ 1,574,863     $ 135,713     $ 76,988     $     $ 1,787,564  
                               
Net income   $ 100,843     $ 33,391     $ (1,927 )   $ (31,468 )   $ 100,839  
Provision for income taxes                       31,468       31,468  
Interest income, net     (4,590 )                       (4,590 )
Depreciation and amortization     97,836       3,087       2,530             103,453  
Share-based compensation expense     6,568       505       72             7,145  
Adjusted EBITDA   $ 200,657     $ 36,983     $ 675     $     $ 238,315  
Adjusted EBITDA Margin     12.7 %     27.3 %     0.9 %           13.3 %
 

Investor Relations Contact

Shane O’Connor, Executive Vice President & CFO
UniFirst Corporation
978-658-8888
[email protected]



Bon Announces Breakthrough Order for $16 Million Gut-Health Products

PR Newswire


XI’AN, China
, July 2, 2025 /PRNewswire/ — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solutions provider in the natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co., Ltd., a leading wellness company in China (“Huahai Keyuan”). The term of the agreement is 24 months with a total contract value of up to US$16 million. Pursuant to the agreement, Huahai Keyuan will market, sell and distribute BON’s natural prebiotic series products in Chinese market.

BON believes their latest natural prebiotic product series marks a significant step forward in gut health, featuring a cutting-edge “Prebiotic + Postbiotic” complex centered on its flagship active ingredient: super prebiotic stachyose. This advanced formulation intends to deliver rapid, robust, and sustained support for gut microbiota, promoting a multi-fold increase in beneficial probiotic populations within a short period while maintaining excellent stability.

With its efficacy and market potential, this solution is poised to help redefine the future of gut health.

Yongwei Hu , Chairman and CEO of BON, stated “As a global leader in ‘prebiotic + postbiotic’ health solutions, we are thrilled to launch a premium gut health product with robust and sustained bioactive properties, and to establish a distribution partnership with Huahai Keyuan—an organization well-regarded for its strong market presence and commercialization expertise.” Mr. Hu added “Huahai Keyuan brings deep experience in introducing innovative health products to the Chinese market, with a proven track record in market expansion and brand development.”

Mr. Hu further stated, “At BON, we believe this strategic collaboration will accelerate our entry into China’s rapidly growing gut health market and unlock substantial growth opportunities for both parties.”

Additionally, Mr. Hu also stated: “This partnership with Huahai Keyuan marks a transformative step in scaling our integrated gut health solutions. We anticipate strong commercial outcomes that will drive both top-line growth and long-term shareholder value.”

About Bon Natural Life Limited (“BON”)

BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit the Company’s website at http://www.bnlus.com.

For more information, please contact:

Cindy Liu | IR
Email: [email protected]

Safe Harbor Statement

This press release contains certain statements that may include “forward-looking statements.” All statements other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,””expects” or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Cision View original content:https://www.prnewswire.com/news-releases/bon-announces-breakthrough-order-for-16-million-gut-health-products-302496652.html

SOURCE Bon Natural Life Limited

Cathexis Successfully Completes the $5.8 Billion Sale of Yondr Group to DigitalBridge and La Caisse

PR Newswire

Transaction represents a successful exit for Cathexis, which founded Yondr in 2018


SAN JUAN, Puerto Rico
, July 2, 2025 /PRNewswire/ — Cathexis Holdings, L.P. (“Cathexis”) today announced the successful completion of the sale of Yondr Group (“Yondr”), a global developer, owner, and operator of hyperscale data centers, to DigitalBridge Group, Inc. (NYSE: DBRG) (“DigitalBridge”) and La Caisse (formerly CDPQ) for $5.8 billion.

Yondr develops and operates data centers to address the complex data center capacity demands of the world’s largest technology companies. As demand for advanced data processing capabilities expands, Yondr has more than 420MW of capacity committed to hyperscalers and significant additional land to support a total potential capacity of over 1GW. The company is well-positioned to capitalize on the growing demand for advanced data processing capabilities driven by ongoing digital transformation, the expansion of cloud solutions, and the rise of AI.

“I am proud to have supported Yondr on its journey since its formation in 2018. Yondr has become a vital infrastructure partner to many of the world’s largest technology companies, and I believe DigitalBridge and La Caisse are the right partners to support Yondr through its next stage of growth. I look forward to seeing what the business will achieve,” said William Harrison, CEO of Cathexis. “While many individuals contributed to the success of Yondr, I would like to thank Paul Cossell (former Chief Executive Officer of Yondr) and Chester Reid (former Chief Financial Officer of Yondr) in particular for their outstanding leadership of and dedication to the company. Paul and Chester have been instrumental in positioning Yondr for this next chapter of growth under new ownership. I wish them continued success in all their future endeavors. I would also like to welcome Aaron Wangenheim, who has been appointed as Chief Executive Officer, and Sandip Mahajan, who has been appointed as Chief Financial Officer, to Yondr, and wish them much success as they lead the company through this exciting next phase with DigitalBridge and La Caisse.”

Citi served as Yondr’s exclusive financial advisor, with White & Case LLP as its legal counsel and PricewaterhouseCoopers as its tax and accounting advisor.

About Cathexis

Cathexis is a private investment holding company based in San Juan, Puerto Rico. The firm’s investment strategy is value-oriented and opportunistic, with a primary focus on private equity, growth equity and venture capital. The firm invests directly in contracting, real estate, energy, data center, and venture capital opportunities. The investment team targets opportunities where the firm’s flexible and permanent capital base, long-term investment horizon, and industry expertise give the firm a significant advantage. Cathexis believes that strong alignment with management teams and operating partners along with its ability to commit long-term capital are key drivers of its success. For more information, visit www.cathexis.com.

About Yondr Group

Yondr Group is a global developer, owner, and operator of hyperscale data centers. The company specializes in delivering and operating dedicated infrastructure that is engineered for scale. As an organisation, our mission —’Global capacity responsible delivery’— ensures that we achieve our vision of a tomorrow without constraints. For more information, visit www.yondrgroup.com.

Media Contacts:

Cathexis
[email protected] 

Yondr Group
Louise Donkor, Marketing Communications Director
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cathexis-successfully-completes-the-5-8-billion-sale-of-yondr-group-to-digitalbridge-and-la-caisse-302496479.html

SOURCE Cathexis Holdings, L.P.

U.S. Gold Corp. officially joins the Russell 3000® and Russell 2000® Indexes in FTSE Russell’s Annual 2025 Reconstitution

PR Newswire

CHEYENNE, Wyo., July 2, 2025 /PRNewswire/ — U.S. Gold Corp. (“U.S. Gold,” the “Company,” “we,” “our” or “us”) (Nasdaq: USAU) is pleased to announce that effective with the U.S. market open on June 30, 2025, the Company was added to the broad-market Russell 3000 Index (the “Russell 3000”) and the small-cap Russell 2000 Index (the “Russell 2000”) as part of the 2025 annual reconstitution of the Russell indexes.

Inclusion in the Russell 2000, which is maintained for one year, is based on inclusion in the broader Russell 3000. The Company’s common stock has also been automatically added to the applicable growth and value indexes. The Company’s common stock experienced an unprecedented amount of trading volume on Friday, June 27, 2025, the business day immediately prior to the reconstitution taking effect.

The Russell 3000 includes the 3,000 largest U.S. public companies by market capitalization. The Russell 2000 is a subset of the Russell 3000, comprising only small-cap companies. The indexes are reconstituted annually by re-ranking companies based on total market capitalization as of the reconstitution rank date, which was April 30th for 2025. Index membership results in automatic inclusion in the relevant growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily based on objective market-capitalization rankings and style attributes.

“The official inclusion in the Russell 3000 not only validates the momentum we’re building but also showcases our team’s dedication to developing the CK Gold Project and delivering value to our shareholders,” said Luke Norman, Chairman of U.S. Gold. Mr. Norman went on to say, “The increase in trading volume signifies heightened market visibility and institutional interest, ultimately broadening our shareholder exposure and attracting generalist investors to the opportunities we offer in the domestic production of strategic minerals and the creation of homegrown jobs.”

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell U.S. indexes, which belong to FTSE Russell, a prominent global index provider.

For more information on the Russell 2000, Russell 3000 and the Russell indexes reconstitution, visit the “Russell Reconstitution” section on the FTSE Russell website.

About U.S. Gold Corp.

U.S. Gold Corp. is a publicly traded, U.S. focused gold and copper exploration and development company. U.S. Gold Corp. has a portfolio of exploration properties. Our CK Gold Project is located in Southeast Wyoming and has a Preliminary Feasibility Study technical report, which was completed by Samuel Engineering Inc. Our Keystone exploration property is on the Cortez Trend in Nevada. Our Challis Gold Project is located in Idaho. For more information about U.S. Gold Corp., please https://www.usgoldcorp.com/.

Cautionary Note Regarding Forward-Looking Statements

Certain statements in this press release are forward-looking within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “proposed,” “aims,” “anticipates”, “forecast,” “estimated,” “believes,” “continues” and “intend,” among others. These forward-looking statements include statements related to the potential benefits of the Company’s inclusion in the Russell indexes, increased visibility and institutional interest, the development of the CK Gold Project, the Company’s ability to deliver value to shareholders, and expectations regarding domestic mineral production and job creation. While management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory, and other risks, contingencies, and uncertainties, most of which are difficult to predict and many of which are beyond the Company’s control. Neither the Company’s inclusion in the Russell indexes nor any increase in trading volume resulting therefrom is any indication of future stock price performance. The Company undertakes no duty to correct or update any information contained herein.

For further information
U.S. Gold Corp.
Investor Relations
+1 800 557 4550
[email protected]
www.usgoldcorp.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/us-gold-corp-officially-joins-the-russell-3000-and-russell-2000-indexes-in-ftse-russells-annual-2025-reconstitution-302495996.html

SOURCE U.S. Gold Corp.